Biological Sample Collection for Cancer
What You Need to Know Before You Apply
What is the purpose of this trial?
This trial aims to accelerate cancer research by studying disease mechanisms and developing new, personalized treatments for cancer patients. It includes two groups: healthy individuals and those diagnosed with solid tumor cancers. This study suits adults diagnosed with a solid tumor cancer or healthy individuals willing to participate as controls.
As a Phase 2 trial, the research focuses on evaluating the treatment's effectiveness in an initial, smaller group, providing participants an opportunity to contribute to groundbreaking advancements in cancer treatment.
Do I need to stop taking my current medications for the trial?
The trial information does not specify whether you need to stop taking your current medications. It's best to discuss this with the trial coordinators or your doctor.
Why are researchers excited about this trial?
Researchers are excited about the Personalized Models for Cancer Research trial because it aims to develop customized approaches to understanding and treating solid tumor cancers. Unlike traditional treatments that apply a one-size-fits-all methodology, this trial explores individualized models, which could lead to more precise and effective treatments tailored to each patient's unique genetic makeup. By focusing on personalizing cancer treatment, this approach has the potential to significantly improve outcomes and reduce side effects compared to conventional therapies.
Who Is on the Research Team?
Laura Andres-Martin, PhD
Principal Investigator
New York Stem Cell Foundation Research Institute
Are You a Good Fit for This Trial?
Inclusion Criteria
Timeline for a Trial Participant
Screening
Participants are screened for eligibility to participate in the trial
Sample Collection
Collection of tumor/organoid and stem cell samples from participants for biobanking
Organoid Development
Development of patient-specific organoid models to study tumor complexity and responses
Functional Testing
Perform drug testing and screens to identify new therapeutic strategies using organoid models
Follow-up
Participants are monitored for safety and effectiveness after sample collection and testing
What Are the Treatments Tested in This Trial?
Interventions
- Biological Sample Collection
How Is the Trial Designed?
2
Treatment groups
Experimental Treatment
Subjects in this group will serve as healthy controls.
Subjects in this group will have a solid tumor cancer diagnosis.
Find a Clinic Near You
Who Is Running the Clinical Trial?
New York Stem Cell Foundation Research Institute
Lead Sponsor
Stevens Institute of Technology
Collaborator
Stevens Institute of Technology
Collaborator
Unbiased Results
We believe in providing patients with all the options.
Your Data Stays Your Data
We only share your information with the clinical trials you're trying to access.
Verified Trials Only
All of our trials are run by licensed doctors, researchers, and healthcare companies.